Keytone Ventures
VC Fund
Beijing, China
Keytone Ventures is a China-focused venture capital firm. Keytone was founded in 2008 when it acquired a portfolio of seven investments from Kleiner Perkins Caufield & Byers. Keytone's investment team includes Joe Zhou, former Founding Managing Partner at KPCB China, and Stella Jin, former partner at IDG-Accel China Growth Fund.
- Total investments:
- 40
- Last investment:
- Lead investor:
- 33%
- Fund size:
- $300M
- Last fund:
Last updated:
For AI agents: llms.txt
Industries Keytone Ventures invests in
Stages Keytone Ventures invests in
Countries Keytone Ventures invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Joe Zhou Zhi Xiong
|
|||
Eric Tao
|
|||
|
Qi Li
|
|||
Investment Focus
Industry
- Mobile 6 (15%)
- Software 6 (15%)
- Manufacturing 5 (13%)
- Artificial Intelligence 5 (13%)
- E-Commerce 4 (10%)
Stage
- Funding Round 9 (23%)
- Series B 7 (18%)
- Series A 6 (15%)
- Series C 6 (15%)
- Angel 4 (10%)
Country
- China 16 (40%)
- United States 11 (28%)
- Singapore 2 (5%)
- South Korea 1 (3%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Joe Zhou Zhi Xiong
Founder and Managing Partner
|
Founder and Managing Partner | Total investments: 6 | Find email | |
|
Eric Tao
Partner
|
Partner | Total investments: 0 | Find email | |
|
Qi Li
Operations Partner
|
Operations Partner | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
|
Moffett AI
|
MoXin is an AI chip designer, providing terminal and cloud AI chip acceleration solutions. | $147.5M / Series C / May 28, 2026 | |
Mirxes
|
MiRXES offers discover, develop, and deliver accurate preventive healthcare solutions for cancer, cardiovascular, metabolic and infectious diseases, and make them accessible to all. | $87M / Series C / Feb 22, 2022 | |
|
Mirxes
|
MiRXES offers discover, develop, and deliver accurate preventive healthcare solutions for cancer, cardiovascular, metabolic and infectious diseases, and make them accessible to all. | $77M / Series C / Jul 08, 2021 | |
PyrAmes, Inc.
|
PyrAmes has developed a paper thin, flexible, ultra low power device for non-invasive monitoring of blood pressure | $6M / Series A / Apr 20, 2021 | |
|
Moffett AI
|
MoXin is an AI chip designer, providing terminal and cloud AI chip acceleration solutions. | $14.2M / Seed / Mar 26, 2021 | |
Moffett AI
|
Moffett is building the world’s next generation AI computation platform, from ground up. They pioneer in deep learning algorithms and build computation platform that the world has never seen - powerful, fast and extremely energy efficient. | $14.2M / Seed / Mar 26, 2021 | |
|
Moffett AI
|
MoXin is an AI chip designer, providing terminal and cloud AI chip acceleration solutions. | $15.3M / Seed / Mar 26, 2021 | |
BD Gene Therapeutics
|
BD Gene Therapeutics is a provider of a gene-editing platform for the treatment of genetic diseases. It uses mRNA delivery technology to achieve safe and efficient delivery of gene-editing tools such as CRISPR. In addition, BD-mRNA technology has important application prospects in the fields of tumor immunity and regenerative medicine. It also usesthe fourth-generation lentiviral vector platform for all types of cells. It has developed antiviral eyedrops and others. | $1.4M / Angel / Jun 22, 2020 | |
|
Moffett AI
|
Moffett is building the world’s next generation AI computation platform, from ground up. They pioneer in deep learning algorithms and build computation platform that the world has never seen - powerful, fast and extremely energy efficient. | $10M / Angel / Mar 06, 2020 | |
|
Moffett AI
|
MoXin is an AI chip designer, providing terminal and cloud AI chip acceleration solutions. | $10M / Angel / Mar 06, 2020 | |
| See all 40 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Keytone Ventures invest in?
Keytone Ventures invests primarily in Mobile, Software and Manufacturing startups, most often at Funding Round and Series B stage. Most of the 40 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Keytone Ventures?
Public channels for Keytone Ventures include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Keytone Ventures?
The team at Keytone Ventures includes Joe Zhou Zhi Xiong (Founder and Managing Partner), Eric Tao (Partner) and Qi Li (Operations Partner). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
